NCT02553018View on ClinicalTrials.gov

Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe

PHASE3CompletedINTERVENTIONAL
Enrollment

278

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Methotrexate

Trial Locations (2)

Unknown

SARAUX, Brest

HUDRY, Paris

Sponsors

Lead Sponsor

Nordic Pharma SAS
All Listed Sponsors
lead

Nordic Pharma SAS

INDUSTRY

NCT02553018 - Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe | Biotech Hunter | Biotech Hunter